Gene expression network analysis provides potential targets against SARS-CoV-2

Código QR

Gene expression network analysis provides potential targets against SARS-CoV-2

Abstract Cell entry of SARS-CoV-2, the novel coronavirus causing COVID-19, is facilitated by host cell angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2). We aimed to identify and characterize genes that are co-expressed with ACE2 and TMPRSS2, and to further explore...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ana I. Hernández Cordero, Xuan Li, Chen Xi Yang, Stephen Milne, Yohan Bossé, Philippe Joubert, Wim Timens, Maarten van den Berge, David Nickle, Ke Hao, Don D. Sin
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/04a4ce5f742b4fb4a05cf20cbace41a1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank
por: Kim Valette, et al.
Publicado: (2021)

Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution
por: Shuyuan Zhang, et al.
Publicado: (2021)

Organ-specific genome diversity of replication-competent SARS-CoV-2
por: Jolien Van Cleemput, et al.
Publicado: (2021)

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
por: Shipo Wu, et al.
Publicado: (2020)

Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses
por: Yongjun Tan, et al.
Publicado: (2020)

Expression of several Phytophthora cinnamomi putative RxLRs provides evidence for virulence roles in avocado.
por: Melissa Joubert, et al.
Publicado: (2021)

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
por: Yfat Yahalom-Ronen, et al.
Publicado: (2020)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
por: Kuldeep Singh Patel, et al.
Publicado: (2020)

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
por: Claudio Counoupas, et al.
Publicado: (2021)

Immunoreactive peptide maps of SARS-CoV-2
por: Nischay Mishra, et al.
Publicado: (2021)

Testing for SARS-CoV-2
por: Popadić Dušan
Publicado: (2021)

SARS-CoV-2 in cardiomyocytes
por: Josef Finsterer
Publicado: (2021)

A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
por: Qingrui Huang, et al.
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
por: Antonio Muruato, et al.
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Antonio Muruato, et al.
Publicado: (2021)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu T, et al.
Publicado: (2021)

Paper-Based Point-of-Care Testing of SARS-CoV-2
por: Yuan Jia, et al.
Publicado: (2021)

Conserved molecular signatures in the spike protein provide evidence indicating the origin of SARS-CoV-2 and a Pangolin-CoV (MP789) by recombination(s) between specific lineages of Sarbecoviruses
por: Bijendra Khadka, et al.
Publicado: (2021)

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
por: Shufen Li, et al.
Publicado: (2021)

Spontaneous Pneumomediastinum: A Possible Severe Condition in SARS-CoV-2 Pneumonia
por: Geoffrey Jacqmin, et al.
Publicado: (2021)

Distinct Metagenomic Signatures in the SARS-CoV-2 Infection
por: Yijun Liu, et al.
Publicado: (2021)

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
por: Xiaodong Tian, et al.
Publicado: (2021)

Mechanisms of Immunothrombosis by SARS-CoV-2
por: María Teresa Hernández-Huerta, et al.
Publicado: (2021)

CLÍNICA Y DIAGNÓSTICO SARS-COV-2
por: María Ester Pizarro
Publicado: (2020)

Hotspot Mutations in SARS-CoV-2
por: Indrajit Saha, et al.
Publicado: (2021)

Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Kevin J Selva, et al.
Publicado: (2021)

Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs.
por: Les Jones, et al.
Publicado: (2021)

Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
por: Hagit Achdout, et al.
Publicado: (2021)

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Xiuyuan Ou, et al.
Publicado: (2020)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih Cucunawangsih, et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP
por: José Zúñiga, et al.
Publicado: (2021)

Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures
por: Michael Laue, et al.
Publicado: (2021)

Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
por: Qingrui Huang, et al.
Publicado: (2021)

Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2
por: Antoni G. Wrobel, et al.
Publicado: (2021)

Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist
por: Andrew MK, et al.
Publicado: (2021)

Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19
por: B. Merrick, et al.
Publicado: (2021)

Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens
por: Fabian Z. X. Lean, et al.
Publicado: (2020)

Sensitive detection and quantification of SARS-CoV-2 in saliva
por: Mustafa Fatih Abasiyanik, et al.
Publicado: (2021)

The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
por: Madeline Loffredo, et al.
Publicado: (2021)

OTRO DESAFIO DE LA NATURALEZA: EL NUEVO CORONAVIRUS VIROLOGÍA Y FISIOPATOLOGÍA DEL SARS-COV-2
por: Gema Pérez A, et al.
Publicado: (2020)